Xiongxiong Li

Jun 26, 2024 | onlinelibrary.wiley.com | Xiongxiong Li |Can Zhou |Ting Xu |Yu Ren

1 INTRODUCTION With the widespread adoption in breast cancer screening, the incidence of ductal carcinoma in situ (DCIS) was accounting for 25% of all new cancer cases,1 with 10% of them presenting in combination with ductal carcinoma in situ with microinvasion (DCIS-MI).2 According to the 8th edition of the American Joint Committee on Cancer (AJCC) staging system for breast cancer, DCIS-MI is defined by the presence of cancer cells that have penetrated the basement membrane and invaded...

Apr 10, 2023 | pubs.rsc.org | Fengping Hou |Shiqi Sun |Yu Tang |Xiongxiong Li

The application of nanoparticles in point-of-care testing (POCT) immunoassays Fengping Hou,   Shiqi Sun,   Sahibzada Waheed Abdullaha,   Yu Tang,   Xiongxiong Li  and  Huichen Guo   Abstract The Covid-19 pandemic let people recognize the importance of the fast and timely detection of pathogens. Recent advances in point-of-care testing (POCT) technology have shown promising results for rapid diagnosis.